Methods
BREAST
This prospective observational cohort study, performed between October 25, 2021, and September 20, 2022, was approved by the Regional Committee on Health Research Ethics and the Danish Data Protection Agency. The study was performed according to the Strengthening the Reporting of Observational Studies in Epidemiology (Patients were included from an ongoing randomized clinical trial (the BREAST-AB trial [Prophylactic Treatment of Breast Implants With a Solution of Gentamicin, Vancomycin and Cefazolin Antibiotics for Women Undergoing Breast Reconstructive Surgery: a Randomized Controlled Trial]